Selective targeting of KRAS mutant cancer cells by a novel small molecule compound

被引：0
|
作者：
Iskandar, Kartini [1 ]
Rezlan, Majidah [1 ]
Yadav, Sanjiv K. [1 ]
Pervaiz, Shazib [1 ]
机构：
[1] Natl Univ Singapore, Singapore 117548, Singapore
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-2605
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2605
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A novel small molecule inhibitor of inactive and active forms of oncogenic mutant KRAS promotes tumor regression in KRASmutated cancer models
    Weaver, D.
    Lou, Y.
    Xu, Z.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S43 - S44
  • [32] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    Xiufeng Pang
    Mingyao Liu
    Chinese Journal of Cancer, 2016, 35 (11) : 571 - 573
  • [33] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    Pang, Xiufeng
    Liu, Mingyao
    CHINESE JOURNAL OF CANCER, 2016, 35 : 92
  • [34] Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities
    Zhang, Jun
    Park, Dongkyoo
    Shin, Dong M.
    Deng, Xingming
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2016, 48 (01) : 11 - 16
  • [35] Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future
    Uras, Iris Z.
    Moll, Herwig P.
    Casanova, Emilio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 30
  • [36] Targeting cancer cells with mutated KRAS with krasin, a novel synthetic cycloheptapeptide
    Sheikhnejad, R.
    Tahoori, F.
    Shokri, B.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S208 - S208
  • [37] Small molecule targeting of the kRAS mid-G-quadruplex for potential pancreatic cancer therapeutics
    Morgan, Rhianna K.
    Brooks, Tracy A.
    CANCER RESEARCH, 2016, 76
  • [38] From intracellular antibody fragments to small molecule inhibitors of mutant KRAS
    Quevedo, Camilo E.
    Cruz, Abimael
    Tulmin, Hanna
    Bataille, Carole J.
    Tanaka, Tomoyuki
    Petch, Donna
    Russell, Angela J.
    Phillips, Simon
    Rabbitts, Terence H.
    CANCER RESEARCH, 2017, 77
  • [39] Insight towards therapeutic susceptibility of KRAS-mutant cancers from MRTX1257, a novel KRAS G12C mutant-selective small-molecule inhibitor.
    Christensen, James G.
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 24 - 24
  • [40] Targeting metabolic peculiarities: a potentially novel therapeutic approach for KRAS-mutant lung cancer?
    Abdel-Rahman, Omar
    JOURNAL OF THORACIC DISEASE, 2016, 8 (08) : E794 - E795
12345